4/A//SEC Filing
Crowley John F 4/A
Accession 0000950170-24-032406
CIK 0001178879other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 7:14 PM ET
Size
8.9 KB
Accession
0000950170-24-032406
Insider Transaction Report
Form 4/AAmended
Crowley John F
DirectorPresident & CEO
Transactions
- Award
Common Stock
2024-01-09+57,620→ 995,492 total - Tax Payment
Common Stock
2024-01-09$13.65/sh−36,865$503,207→ 958,627 total - Sale
Common Stock
2024-01-10$13.65/sh−31,614$431,452→ 927,013 total
Footnotes (3)
- [F1]Granted for the achievement of the 2021 PRSU TSR goal as determined by the Compensation and Leadership Development Committee of the Board of Directors.
- [F2]On January 11, 2024, the reporting person filed a Form 4 which inadvertently excluded the acquisition of shares granted for the achievement of the TSR portion of the 2021 PRSU award and inadvertently reported incorrect holdings following both shares being withheld for taxes and a sale transaction. This Form 4 amendment reflects these transactions and the reporting person's holdings following these transactions correctly.
- [F3]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.48 to $13.96 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
AMICUS THERAPEUTICS, INC.
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001400973
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 7:14 PM ET
- Size
- 8.9 KB